P K Henneberger1, X Liang1, L Lillienberg2, A Dahlman-Höglund2, K Torén2, E Andersson2. 1. Division of Respiratory Disease Studies, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia, USA. 2. Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
Abstract
BACKGROUND: The exacerbation of asthma by workplace conditions is common, but little is known about which agents pose a risk. OBJECTIVE: We used data from an existing survey of adults with asthma to identify occupational exposures associated with severe exacerbation of asthma. DESIGN: Questionnaires were completed by 557 working adults with asthma. Severe exacerbation of asthma in the past 12 months was defined as asthma-related hospitalization, or reports of both unplanned asthma care and treatment with a short course of oral corticosteroids. Occupational exposures for the same time period were assessed using an asthma-specific job exposure matrix. We modeled severe exacerbation to yield prevalence ratios (PRs) for exposures while controlling for potential confounders. RESULTS: A total of 164 participants (29%) were positive for severe exacerbation, and 227 (40.8%) were assessed as being exposed to asthma agents at work. Elevated PRs were observed for several specific agents, notably the irritant subcategories of environmental tobacco smoke (PR 1.84, 95%CI 1.34-2.51) among all participants, inorganic dusts (PR 2.53, 95%CI 1.37-4.67) among men, and the low molecular weight subcategory of other highly reactive agents (PR 1.97, 95%CI 1.08-3.60) among women. CONCLUSION: Among working adults with asthma, severe exacerbation was associated with several occupational agents.
BACKGROUND: The exacerbation of asthma by workplace conditions is common, but little is known about which agents pose a risk. OBJECTIVE: We used data from an existing survey of adults with asthma to identify occupational exposures associated with severe exacerbation of asthma. DESIGN: Questionnaires were completed by 557 working adults with asthma. Severe exacerbation of asthma in the past 12 months was defined as asthma-related hospitalization, or reports of both unplanned asthma care and treatment with a short course of oral corticosteroids. Occupational exposures for the same time period were assessed using an asthma-specific job exposure matrix. We modeled severe exacerbation to yield prevalence ratios (PRs) for exposures while controlling for potential confounders. RESULTS: A total of 164 participants (29%) were positive for severe exacerbation, and 227 (40.8%) were assessed as being exposed to asthma agents at work. Elevated PRs were observed for several specific agents, notably the irritant subcategories of environmental tobacco smoke (PR 1.84, 95%CI 1.34-2.51) among all participants, inorganic dusts (PR 2.53, 95%CI 1.37-4.67) among men, and the low molecular weight subcategory of other highly reactive agents (PR 1.97, 95%CI 1.08-3.60) among women. CONCLUSION: Among working adults with asthma, severe exacerbation was associated with several occupational agents.
Authors: Daniel Menzies; Arun Nair; Peter A Williamson; Stuart Schembri; Mudher Z H Al-Khairalla; Martyn Barnes; Tom C Fardon; Lesley McFarlane; Gareth J Magee; Brian J Lipworth Journal: JAMA Date: 2006-10-11 Impact factor: 56.272
Authors: Patrick Goodman; Michelle Agnew; Marie McCaffrey; Gillian Paul; Luke Clancy Journal: Am J Respir Crit Care Med Date: 2007-01-04 Impact factor: 21.405
Authors: Helen K Reddel; D Robin Taylor; Eric D Bateman; Louis-Philippe Boulet; Homer A Boushey; William W Busse; Thomas B Casale; Pascal Chanez; Paul L Enright; Peter G Gibson; Johan C de Jongste; Huib A M Kerstjens; Stephen C Lazarus; Mark L Levy; Paul M O'Byrne; Martyn R Partridge; Ian D Pavord; Malcolm R Sears; Peter J Sterk; Stuart W Stoloff; Sean D Sullivan; Stanley J Szefler; Mike D Thomas; Sally E Wenzel Journal: Am J Respir Crit Care Med Date: 2009-07-01 Impact factor: 21.405
Authors: Susan M Tarlo; John Balmes; Ronald Balkissoon; Jeremy Beach; William Beckett; David Bernstein; Paul D Blanc; Stuart M Brooks; Clayton T Cowl; Feroza Daroowalla; Philip Harber; Catherine Lemiere; Gary M Liss; Karin A Pacheco; Carrie A Redlich; Brian Rowe; Julia Heitzer Journal: Chest Date: 2008-09 Impact factor: 9.410
Authors: Frank de Vocht; Jan-Paul Zock; Hans Kromhout; Jordi Sunyer; Josep M Antó; Peter Burney; Manolis Kogevinas Journal: Am J Ind Med Date: 2005-05 Impact factor: 2.214
Authors: Manolis Kogevinas; Jan-Paul Zock; Debbie Jarvis; Hans Kromhout; Linnéa Lillienberg; Estel Plana; Katja Radon; Kjell Torén; Ada Alliksoo; Geza Benke; Paul D Blanc; Anna Dahlman-Hoglund; Angelo D'Errico; Michel Héry; Susan Kennedy; Nino Kunzli; Bénédicte Leynaert; Maria C Mirabelli; Nerea Muniozguren; Dan Norbäck; Mario Olivieri; Félix Payo; Simona Villani; Marc van Sprundel; Isabel Urrutia; Gunilla Wieslander; Jordi Sunyer; Josep M Antó Journal: Lancet Date: 2007-07-28 Impact factor: 79.321
Authors: R Abrahamsen; A K M Fell; M V Svendsen; E Andersson; K Torén; P K Henneberger; J Kongerud Journal: BMJ Open Date: 2017-03-22 Impact factor: 2.692
Authors: Angelica I Tiotiu; Silviya Novakova; Marina Labor; Alexander Emelyanov; Stefan Mihaicuta; Plamena Novakova; Denislava Nedeva Journal: Int J Environ Res Public Health Date: 2020-06-24 Impact factor: 3.390